| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,680 | $30 | $227K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,020 | $100 | $191.8K |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 3,500 | $40 | $122.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,100 | $30 | $80.6K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,270 | $30 | $61.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,560 | $10 | $55.6K |
| J0897 | Injection, denosumab, 1 mg | 2,760 | $20 | $52.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 290 | $140 | $41.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $110 | $41.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 500 | $50 | $26.2K |